ClassID:

21647

A61K2300/00 - page 68 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#20101
20070049529
2007-03-01

Methods of using cytokine zalpha11 ligand

#20102
20070049516
2007-03-01

Use of Insulin for the Treatment of Cartilaginous Disorders

#20103
20070048845
2007-03-01

CYTOKINE ZALPHA11 LIGAND FUSION PROTEINS

#20104
20070048830
2007-03-01

Growth factor homolog ZVEGF4

#20105
20070048829
2007-03-01

Growth factor homolog zvegf4

#20106
20070048794
2007-03-01

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

#20107
20070048397
2007-03-01

Anti-inflammatory compositions and personal care compositions comprising olive leaf () extract

#20108
20070048396
2007-03-01

Anti-inflammatory compositions and methods of use

#20109
20070048395
2007-03-01

Antibacterial treatment and composition

#20110
20070048393
2007-03-01

Topical turmeric skin care products

#20111
20070048392
2007-03-01

Plant extract mixtures and their uses

#20112
20070048387
2007-03-01

Tissue disruption treatment and composition for use thereof

#20113
20070048386
2007-03-01

MEDICAMENT FOR TREATING INFLAMMATORY AND NON-INFLAMMATORY ARTHRITIS

#20114
20070048381
2007-03-01

Methods for promoting growth of bone, ligament, and cartilage

#20115
20070048367
2007-03-01

Herbal composition for treating morning sickness

#20116
20070048354
2007-03-01

Synthetic nutritional formulations

#20117
20070048336
2007-03-01

Combination therapy of peptide vaccination and estramustine treatment

#20118
20070048335
2007-03-01

Methods for treating pain and hyperhidrosis

#20119
20070048325
2007-03-01

Combination therapies for inhibiting integrin-extracellular matrix interactions

#20120
20070048317
2007-03-01

Method of treating fibroproliferative disorders

#20121
20070048316
2007-03-01

METHOD OF REDUCING PROLIFERATION OF CELLS IN A MAMMAL

#20122
20070048306
2007-03-01

Method for generating anti-variable region monoclonal antibodies

#20123
20070048296
2007-03-01

Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation

#20124
20070048295
2007-03-01

Method for preparing alginate capsules

#20125
20070048284
2007-03-01

Cardiac arrhythmia treatment methods

#20126
20070048281
2007-03-01

HCV COMBINATION THERAPY

#20127
20070048264
2007-03-01

METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY

#20128
20070048260
2007-03-01

Cytokine zalpha11 ligand fusion proteins

#20129
20070048259
2007-03-01

Method of use of cytokine ZALPHA11 ligand

#20130
20070048255
2007-03-01

Method for treatment of demyelinating central nervous system disease

#20131
20070048254
2007-03-01

GENERATION OF DENDRITIC CELLS

#20132
20070048250
2007-03-01

Methods of treating concomitant constipation in a cancer treatment regimen including imexon

#20133
20070048246
2007-03-01

Novel skin care compositions

#20134
20070048245
2007-03-01

Cosmetic composition to accelerate repair of functional wrinkles

#20135
20070048244
2007-03-01

Cosmetic composition for cleaning the skin

#20136
20070048243
2007-03-01

Anti-aging composition containing criste marine and padina pavonica extracts

#20137
20070048234
2007-03-01

COMPOSITIONS AND METHODS FOR TREATING ACNE

#20138
20070048229
2007-03-01

Buccal, polar and non-polar spray containing atropine

#20139
20070048219
2007-03-01

Antibody fragment-polymer conjugates and uses of same

#20140
20070043120
2007-02-22

Therapeutic combination for painful medical conditions

#20141
20070043116
2007-02-22

Method for preventing and/or treating neurodegenerative diseases

#20142
20070043112
2007-02-22

Use of non-opiates for the potentation of opiates

#20143
20070043110
2007-02-22

Nontoxic potentiation sensitization of ovarian cancer therapy by supplementary treatment with vitamins

#20144
20070043106
2007-02-22

Alpha-lipoic acid concentrate

#20145
20070043097
2007-02-22

Medicaments containing famotidine and ibuprofen and administration of same

#20146
20070043096
2007-02-22

Unit dose form with ibuprofen-famotidine admixture

#20147
20070043076
2007-02-22

Substituted 2-arylmethylene-n-aryl-n'aryl-malonamides and analogs as activators of caspases and inducers of apoptosis

#20148
20070043070
2007-02-22

Weak base salts

#20149
20070043055
2007-02-22

Dihydropteridinones in the treatment of respiratory diseases

#20150
20070043054
2007-02-22

Enzyme cofactor combination for supplementing pyruvate dehydrogenase and alpha ketogluterate dehydrogenase complexes

#20151
20070043052
2007-02-22

Reverse-turn mimetics and method relating thereto

#20152
20070043034
2007-02-22

Chlorine Ion Uptake Modulators and Uses Thereof

#20153
20070043032
2007-02-22

Composition comprising a benzodiazepine agonist and a benzodiazepine antagonist

#20154
20070043012
2007-02-22

Methods to enhance chemotherapy

#20155
20070043006
2007-02-22

Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis

#20156
20070043005
2007-02-22

TREATMENT OF HYPERPROLIFERATIVE DISEASES USING HIGH DOSES OF ACTIVE VITAMIN D

#20157
20070043000
2007-02-22

Immunosuppresive effects of pteridine derivatives

#20158
20070042998
2007-02-22

Medical cosmetic method for reducing adipose tissue and for initiating lipolysis through subcutaneous and intracutaneous injections and customized composition compounded from pharmaceutical agents for use therein

#20159
20070042991
2007-02-22

Modified 2′ and 3′-nucleoside prodrugs for treating infections

#20160
20070042990
2007-02-22

2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#20161
20070042973
2007-02-22

Treatment of pain and fever

#20162
20070042972
2007-02-22

Compositions and methods for optimizing exercise recovery

#20163
20070042957
2007-02-22

TYPE V PHOSPHODIESTERASE INHIBITORS AND NATRIURETIC POLYPEPTIDES

#20164
20070042953
2007-02-22

Antiepileptogenic complex of albumin with docosahexaenoate

#20165
20070042951
2007-02-22

Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides

#20166
20070042943
2007-02-22

Cyclosporin galenic forms

#20167
20070042940
2007-02-22

Modified 2′ and 3′-nucleoside prodrugs for treating infections

#20168
20070042939
2007-02-22

Modified 2′ and 3′-nucleoside prodrugs for treating infections

#20169
20070042492
2007-02-22

Sequences facilitating penetration of a substance of interest

#20170
20070042437
2007-02-22

Treatment of Alzheimer's Disease

#20171
20070042359
2007-02-22

Binding molecules capable of neutralizing west nile virus and uses thereof

#20172
20070042063
2007-02-22

Protein kinase modulation by hops and products

#20173
20070042062
2007-02-22

Novel anti-diabetic herbal formulation

#20174
20070042060
2007-02-22

Methods to treat one or all of the defined etiologies of female sexual Dysfunction

#20175
20070042059
2007-02-22

Methods for modulating eicosanoid metabolism

#20176
20070042058
2007-02-22

Delivery system for appetite suppressant

#20177
20070042057
2007-02-22

Compositions for the treatment and prevention of diabetes mellitus

#20178
20070042056
2007-02-22

Anti-stress agent

#20179
20070042055
2007-02-22

Herbal formulations and cigarettes containing same useful in controlling body weight

#20180
20070042054
2007-02-22

FUNCTIONAL APHRODISIAC ROLLED HERBAL BIDIS AND CIGARETTES

#20181
20070042053
2007-02-22

Medicinal herbal composition for treating infection

#20182
20070042050
2007-02-22

Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression

#20183
20070042048
2007-02-22

Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments

#20184
20070042040
2007-02-22

Methods and compositions using gonadotropin hormone releasing hormone

#20185
20070042037
2007-02-22

Pharmaceutical composition containing levodopa and carbidopa

#20186
20070042026
2007-02-22

Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions

#20187
20070042019
2007-02-22

Method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein

#20188
20070042014
2007-02-22

Combination of a serotonin reuptake inhibitor and loxapine

#20189
20070042009
2007-02-22

Topical composition for delivery of salicylates

#20190
20070042008
2007-02-22

Compositions containing phosphatidylcholine and essential fatty acids

#20191
20070042007
2007-02-22

Topical composition for delivery of salicylate esters

#20192
20070041994
2007-02-22

Compositions and methods for treating prostate disorders

#20193
20070041993
2007-02-22

Compositions and methods for symptomatic relief

#20194
20070041992
2007-02-22

Compositions and methods for inactivating or suppressing inflammatory cells

#20195
20070041974
2007-02-22

CYTOKINE ZALPHA11 LIGAND ANTIBODIES

#20196
20070041956
2007-02-22

Vaccine immunotherapy for immune suppressed patients

#20197
20070041955
2007-02-22

Hedgehog signaling promotes the formation of three dimensional cartilage matrices

#20198
20070041945
2007-02-22

NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID

#20199
20070041939
2007-02-22

Modified cytokines for use in cancer therapy

#20200
20070041906
2007-02-22

Bone substitute composition

#20201
20070041866
2007-02-22

Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant

#20202
20070039064
2007-02-15

Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse

#20203
20070039063
2007-02-15

Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse

#20204
20070037889
2007-02-15

Anticancer composition comprising obovatol or obovatal

#20205
20070037887
2007-02-15

Blockade of mtor to prevent a hormonal adaptive response

#20206
20070037886
2007-02-15

Bone marrow erythroid progenitor cell(s) differentiation inducer

#20207
20070037879
2007-02-15

Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease

#20208
20070037878
2007-02-15

Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease

#20209
20070037861
2007-02-15

Enhanced method of treatment of growth disorders

#20210
20070037860
2007-02-15

Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy

#20211
20070037857
2007-02-15

Triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors

#20212
20070037852
2007-02-15

Migrastatin analogs and uses thereof

#20213
20070037848
2007-02-15

Treatment of neurological conditions

#20214
20070037835
2007-02-15

Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid

#20215
20070037833
2007-02-15

Compositions and methods for inhibiting neurodegeneration

#20216
20070037831
2007-02-15

Methods of using PDE 5 inhibitors for the treatment of congestive heart failure

#20217
20070037825
2007-02-15

Enhancing the effect of radioimmunotherapy in the treatment of tumors

#20218
20070037797
2007-02-15

Method of reducing the risk of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which favor CV events

#20219
20070037781
2007-02-15

Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient

#20220
20070037779
2007-02-15

Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof

#20221
20070037772
2007-02-15

Pyrazolidinol compounds

#20222
20070037755
2007-02-15

Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors

#20223
20070037740
2007-02-15

Combination therapy with glatiramer acetate and alphacalcidol for the treatment of multiple sclerosis

#20224
20070037739
2007-02-15

Compounds useful in coating stents to prevent and treat stenosis and restenosis

#20225
20070037738
2007-02-15

Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions

#20226
20070037737
2007-02-15

Composition and method for the repair and regeneration of cartilage and other tissues

#20227
20070037735
2007-02-15

2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#20228
20070037249
2007-02-15

Molecules that block viral infectivity and methods of use thereof

#20229
20070036876
2007-02-15

Injectable capsaicin

#20230
20070036874
2007-02-15

Compositions and methods for controlling glucose and lipid uptake from foods

#20231
20070036873
2007-02-15

Method of treatment or management of stress

#20232
20070036870
2007-02-15

Aiding of cognitive function

#20233
20070036869
2007-02-15

Methods for prophylactic and therapeutic nutritional supplementation

#20234
20070036862
2007-02-15

Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof

#20235
20070036857
2007-02-15

Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin

#20236
20070036837
2007-02-15

Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares

#20237
20070036834
2007-02-15

Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration

#20238
20070036829
2007-02-15

Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye

#20239
20070036821
2007-02-15

Seaweed extract composition for retardation of cardiovascular disorders and preservation of healthy cardiovascular function

#20240
20070036798
2007-02-15

Method and composition for reconforming multi-epitopic antigens to initiate an immune response

#20241
20070036795
2007-02-15

Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist

#20242
20070036790
2007-02-15

TREATMENT WITH ANTI-VEGF ANTIBODIES

#20243
20070036766
2007-02-15

Tissue graft composition comprising autologous bone marrow and purified autologous thrombin

#20244
20070036755
2007-02-15

TREATMENT WITH ANTI-VEGF ANTIBODIES

#20245
20070036754
2007-02-15

TREATMENT WITH ANTI-VEGF ANTIBODIES

#20246
20070036753
2007-02-15

TREATMENT WITH ANTI-VEGF ANTIBODIES

#20247
20070036751
2007-02-15

Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies

#20248
20070036748
2007-02-15

Activation of Egr-1 promoter by DNA damaging chemotherapeutics

#20249
20070036747
2007-02-15

Pharmaceutical combination useful for stem cell mobilization

#20250
20070036744
2007-02-15

Treatment or prevention of respiratory viral infections with alpha thymosin peptides

#20251
20070036742
2007-02-15

Methods and compositions for modulating hair growth or regrowth

#20252
20070036737
2007-02-15

PRODUCTS FOR TOPICAL APPLICATION COMPRISING LYSOPHOSPHOLIPIDS AND FATTY ACIDS

#20253
20070036732
2007-02-15

Stable topiramate formulations

#20254
20070036719
2007-02-15

Prostate cancer diagnosis and treatment

#20255
20070032548
2007-02-08

Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions

#20256
20070032546
2007-02-08

Formulations comprising fenofibrate and a statin, and related methods of treatment

#20257
20070032537
2007-02-08

5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases

#20258
20070032491
2007-02-08

Combination of a glycine/nmda antagonist and a tachykinin nk-1 receptor antagonist for use in the treatment of neurodegeneration

#20259
20070032481
2007-02-08

Pyrimidine compounds as serotonin receptor modulators

#20260
20070032480
2007-02-08

Treatment of ischemia-induced arrhythmias

#20261
20070032467
2007-02-08

Method for treating hyperlipidemia

#20262
20070032465
2007-02-08

Pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha

#20263
20070032457
2007-02-08

Combination therapy for cancer treatment

#20264
20070032453
2007-02-08

ADJUVANT CHEMOTHERAPY FOR ANAPLASTIC GLIOMAS

#20265
20070032450
2007-02-08

New compositions and methods for the treatment of inflammation

#20266
20070032449
2007-02-08

Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections

#20267
20070032428
2007-02-08

Antimicrobial agents

#20268
20070032425
2007-02-08

Compositions for diabetes treatment and prophylaxis

#20269
20070032424
2007-02-08

Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents

#20270
20070032422
2007-02-08

METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

#20271
20070032420
2007-02-08

Treating diabetes with glucagon-like peptide-1 secretagogues

#20272
20070032418
2007-02-08

Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same

#20273
20070032407
2007-02-08

Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections

#20274
20070032404
2007-02-08

Methods for treating diabetes and related disorders using pde10a inhibitors

#20275
20070031976
2007-02-08

Oxygen Indicator for Use in Medical Products

#20276
20070031537
2007-02-08

Infant or follow-on formula

#20277
20070031521
2007-02-08

Synergistic composition for the treatment of diabetes mellitus

#20278
20070031518
2007-02-08

Cytokine modulators and related methods of use

#20279
20070031516
2007-02-08

Composition for the prevention and treatment of cellulitis

#20280
20070031513
2007-02-08

Carbostyril derivatives and mood stabilizers for treating mood disorders

#20281
20070031511
2007-02-08

Method of treatment

#20282
20070031510
2007-02-08

Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto

#20283
20070031509
2007-02-08

Breakthrough to cure psoriasis, psoriatic arthritis and treatment of other unrelated skin disorders, and external rectal and genital itching

#20284
20070031497
2007-02-08

Gastric acid secretion inhibiting composition

#20285
20070031489
2007-02-08

Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness

#20286
20070031486
2007-02-08

Nutritional supplement for use under physiologically stressful conditions

#20287
20070031476
2007-02-08

Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)

#20288
20070031472
2007-02-08

Steroid-containing sustained release intraocular implants and related methods

#20289
20070031462
2007-02-08

Powder exfoliating compositions and methods for producing the same

#20290
20070031413
2007-02-08

TREATMENT WITH ANTI-VEGF ANTIBODIES

#20291
20070031403
2007-02-08

Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use

#20292
20070031400
2007-02-08

Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs

#20293
20070031398
2007-02-08

One of several enzyme-containing compounds, dietetic food products and drugs produced from and the use therefor for medical purpose

#20294
20070031397
2007-02-08

Compositions and methods for enhancing axon regeneration

#20295
20070031391
2007-02-08

Neural stem cells and use thereof for brain tumor therapy

#20296
20070031385
2007-02-08

Apparatus and method to treat a wound area

#20297
20070031381
2007-02-08

Recombinant adenoviral vector and method of use

#20298
20070031375
2007-02-08

Antibodies against IL-16 antagonist peptides

#20299
20070031374
2007-02-08

Combination therapy

#20300
20070031373
2007-02-08

Reversal of Adult Onset Disorders with Granulocyte-Colony Stimulating Factors

#20301
20070031372
2007-02-08

Vaccine immunotherapy for immune suppressed patients

#20302
20070031367
2007-02-08

Composition and method for neck skin firming

#20303
20070031364
2007-02-08

Keratin gel and the types 2,4 and 6 of collagens of frog protein topical use or for lamina preparation use, such as dressing powdering in food and complements use and in cosmetic mask manufacturing or in solutions used in cosmetic formulation and medical/pharmaceutical

#20304
20070031347
2007-02-08

Powdered Medicaments Containing A Tiotropium Salt and Salmeterol Xinafoate

#20305
20070031341
2007-02-08

Methods of delivering therapeutics to the brain

#20306
20070029001
2007-02-08

Multiple chamber container

#20307
20070028311
2007-02-01

Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15

#20308
20070027218
2007-02-01

Pharmaceutical compositions comprising higher primary alcohols and ezetimibe and process of preparation thereof

#20309
20070027203
2007-02-01

Method of treating inflammatory arthritis

#20310
20070027201
2007-02-01

Use of progesterone receptor modulators

#20311
20070027197
2007-02-01

Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers

#20312
20070027195
2007-02-01

Novel compositions comprising higher primary alcohols and nicottinic acid and process of preparation thereof

#20313
20070027176
2007-02-01

Compositions for veterinary and medical applications

#20314
20070027175
2007-02-01

Antineoplastic activities of ellipticine and its derivatives

#20315
20070027172
2007-02-01

Crystalline pharmaceutical

#20316
20070027169
2007-02-01

XIAP-targeted prostate cancer therapy

#20317
20070027130
2007-02-01

Tricyclic 6-alkylidene-penem beta-lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic

#20318
20070027127
2007-02-01

Treatment of inflammatory oral diseases with a combination of inhibitors of TNF-alpha and immunosuppressive agents

#20319
20070027124
2007-02-01

Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

#20320
20070027123
2007-02-01

Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

#20321
20070027122
2007-02-01

Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

#20322
20070027120
2007-02-01

Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes

#20323
20070027104
2007-02-01

Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#20324
20070027093
2007-02-01

Anorectic

#20325
20070027081
2007-02-01

Method for inducing deposition and maturation of bone comprising a co-therapeutic regimen of LMP-1 and BMP-2

#20326
20070027080
2007-02-01

Method for treatment of vitiligo

#20327
20070027077
2007-02-01

Pharmaceutical compositions comprising factor VII polypeptides and factor XI polypeptides

#20328
20070027076
2007-02-01

Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma

#20329
20070027066
2007-02-01

Modified 2′ and 3′-nucleoside prodrugs for treating infections

#20330
20070027065
2007-02-01

Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#20331
20070026441
2007-02-01

Methods for reducing viral load in HIV-1-infected patients

#20332
20070026091
2007-02-01

Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels and for the prevention and treatment of cancer

#20333
20070026088
2007-02-01

Pharmaceutical Antidiabetic Composition

#20334
20070026085
2007-02-01

Antimicrobial and antiviral composition

#20335
20070026054
2007-02-01

Transdermal pharmaceutical preparation containing active substance combinations, for treating Parkinson's disease

#20336
20070026045
2007-02-01

Reinforced matrices

#20337
20070026044
2007-02-01

Use of VEGF For Treating Bone Defects

#20338
20070026036
2007-02-01

Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease

#20339
20070026024
2007-02-01

Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant

#20340
20070026014
2007-02-01

Interferon beta in severe acute respiratory syndrome (sars)

#20341
20070026001
2007-02-01

APO-2 ligand-anti-her-2 antibody synergism

#20342
20070026000
2007-02-01

APO-2L receptor agonist and CPT-11 synergism

#20343
20070025999
2007-02-01

TREATMENT WITH ANTI-VEGF ANTIBODIES

#20344
20070025998
2007-02-01

METHODS FOR ENHANCING THE EFFICACY OF CANCER THERAPY

#20345
20070025990
2007-02-01

Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders

#20346
20070025988
2007-02-01

Method for Treating Lupus

#20347
20070025979
2007-02-01

Coagulation proteins, coagulation-anticoagulation protein complexes, derivatives thereof and their uses

#20348
20070025964
2007-02-01

HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

#20349
20070025958
2007-02-01

Vaccine immunotherapy

#20350
20070025957
2007-02-01

Vascular targeting of ocular neovascularization

#20351
20070025953
2007-02-01

Co-therapy for diabetic conditions

#20352
20070025950
2007-02-01

COMPOSITION AND METHOD FOR TREATING CELLULITE

#20353
20070025933
2007-02-01

Photoprotector and/or photoimmunoprotector compositions of the skin and their uses

#20354
20070025927
2007-02-01

ODORLESS FORMULATION FOR TREATING MUCOSAL DISCONTINUITIES

#20355
20070025925
2007-02-01

Method of attenuating neurogenic swelling or neurogenic inflammation

#20356
20070025924
2007-02-01

Method of attenuating swelling or inflammation

#20357
20070025922
2007-02-01

Method of attenuating neurogenic pain

#20358
20070025919
2007-02-01

Systems and methods for delivery of a therapeutic agent

#20359
20070025910
2007-02-01

Anticancer therapy

#20360
20070023278
2007-02-01

Apparatus for automatically feeding the silver wire into the solution

#20361
20070022960
2007-02-01

Method for the production of an agent from larvae in flies for treating wounds and agent produced according to said method

#20362
20070021704
2007-01-25

Treatment of leg ulcers using placenta derived collagen biofabric

#20363
20070021697
2007-01-25

System and method for use of agent in combination with subatmospheric tissue treatment

#20364
20070021509
2007-01-25

Phosphate transport inhibitors

#20365
20070021508
2007-01-25

Method for treatment of Helicobacter pylori infection and/or an associated disease

#20366
20070021505
2007-01-25

Prevention and treatment of ophthalmic complications of diabetes

#20367
20070021501
2007-01-25

Methods of treating epileptogenesis

#20368
20070021500
2007-01-25

Methods for neuroprotection

#20369
20070021497
2007-01-25

VITAMIN E COMPOSITIONS

#20370
20070021491
2007-01-25

Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events

#20371
20070021395
2007-01-25

Compositions for reducing the incidence of drug induced arrhythmia

#20372
20070021379
2007-01-25

Methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities

#20373
20070021378
2007-01-25

Heparin compositions and selectin inhibition

#20374
20070021377
2007-01-25

Pharmaceutical composition comprising a macrolide immunomodulator

#20375
20070021376
2007-01-25

Supplement composition and method of use in enhancement of methylation process

#20376
20070021360
2007-01-25

Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase

#20377
20070021357
2007-01-25

Treatment of inflammatory conditions

#20378
20070021352
2007-01-25

PREVENTION AND TREATMENT OF HEARING DISORDERS

#20379
20070021340
2007-01-25

Use of blood coagulation factor XIII for treating hemophilia A

#20380
20070021339
2007-01-25

GLP-1 pharmaceutical compositions

#20381
20070021333
2007-01-25

Pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins

#20382
20070021326
2007-01-25

Composition and its Therapeutic Use

#20383
20070020704
2007-01-25

Diaryl ureas with kinase inhibiting activity

#20384
20070020352
2007-01-25

Treatment modalities for autoimmune diseases

#20385
20070020349
2007-01-25

Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them

#20386
20070020348
2007-01-25

Composition for treating hepatitis C

#20387
20070020347
2007-01-25

Bioavailability enhancing activity of Carum carvi extracts and fractions thereof

#20388
20070020346
2007-01-25

Botanical anticancer formulations

#20389
20070020343
2007-01-25

Nutrient supplements and methods for treating autism and for preventing the onset of autism

#20390
20070020342
2007-01-25

Non-irritating compositions containing zinc salts

#20391
20070020341
2007-01-25

Method for preparing peritoneal dialysate

#20392
20070020340
2007-01-25

Fish oil products for reducing cholesterol, low density lipoprotein, and hypertension

#20393
20070020332
2007-01-25

Tannate compositions, methods of making and methods of use

#20394
20070020330
2007-01-25

Compositions comprising azelastine and methods of use thereof

#20395
20070020320
2007-01-25

Wound dressing and methods of making and using the same

#20396
20070020313
2007-01-25

Composition of amylase inhibitors and fibers to reduce the absorption of starch in human digestion from starchy foods, and to reduce the glycemic index of starchy foods

#20397
20070020299
2007-01-25

Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid

#20398
20070020298
2007-01-25

Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid

#20399
20070020297
2007-01-25

System and method for the treatment of cancer, including cancers of the central nervous system

#20400
20070020296
2007-01-25

Mycoplasma hyopneumoniae bacterin vaccine